Related Experiment Video
Updated: Apr 13, 2026

A Quantitative Sensory Testing Paradigm to Obtain Measures of Pain Processing in Patients Undergoing Breast Cancer Surgery
Published on: January 18, 2018
Classification of neuropathic pain in cancer patients
Elaine G Boland1, Matthew R Mulvey, Michael I Bennett
1aQueen's Centre for Oncology and Haematology, Hull and East Yorkshire Hospitals NHS Trust and Hull York Medical School, University of Hull, Hull bAcademic Unit of Palliative Care, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK.
Purpose Of Review:
Neuropathic pain can affect up to 40% in patients with cancer, which could be related to the tumour, treatment or comorbid diseases. Effective assessment to diagnose neuropathic pain is crucial in order to choose the right treatment.
Recent Findings:
There is to date no systematic classification system; the Neuropathic Pain Special Interest Group of the International Association for the Study of Pain developed a neuropathic pain grading system intended to be used for both clinical and research purposes, and a recent review describes a step-by-step process for applying the grading system in a clinical setting for cancer pain.
Summary:
We have combined these recommendations to outline a clinically relevant process to classify neuropathic pain in patients with cancer.
Related Concept Videos
Nociception
Pain
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Analgesia and Pain Management
Cancer
Cancer Survival Analysis

